Cathie Wood’s ARK Invest Buys Over 415,000 Shares of Teladoc
A few of Cathie Wood's Ark Invest exchange-traded funds buy over 415,000 shares of Teladoc on November 18.
Some of the ARK Invest exchange-traded funds run by ETF star Cathie Wood made a huge purchase on Thursday. The funds bought over 415,000 shares altogether of Teladoc Health Inc. (NYSE: TDOC), as the prices of these ETFs bounced back on Thursday. Note that these funds are up handily in the past year.
Here’s a look at the purchases:
- ARK Fintech Innovation ETF (NYSEARCA: ARKF) bought 40,224 shares.
- ARK Genomic Revolution ETF (NYSEARCA: ARKG) purchased 78,216 shares.
- ARK Innovation ETF (NYSEARCA: ARKK) added 234,681 shares.
- ARK Next Generation Internet ETF (NYSEARCA: ARKW) bought 62,024 shares.
At Thursday’s closing price, this would have valued these purchases at roughly $51.5 million. Even though this is a small fraction of the total holdings, every little bit counts. These funds are up more than 14% in the past 52 weeks, with the exception of the Genomic Revolution ETF, which is actually down 6%.
Check out all of the ARK Invest buys for Thursday:
| Fund | Ticker | Name | Shares |
|---|---|---|---|
| ARKF | KSPILI | KASPI.KZ | 11,813 |
| ARKF | TDOC | TELADOC HEALTH | 40,224 |
| ARKG | ALLO | ALLOGENE THERAPEUTICS | 214,497 |
| ARKG | BNR | BURNING ROCK BIOTECH | 46,455 |
| ARKG | TDOC | TELADOC HEALTH | 78,216 |
| ARKK | TDOC | TELADOC HEALTH | 234,681 |
| ARKK | SKLZ | SKILLZ | 257,636 |
| ARKK | NTLA | INTELLIA THERAPEUTICS | 1,415 |
| ARKK | MTLS | MATERIALISE | 26,915 |
| ARKK | BEAM | BEAM THERAPEUTICS | 9,760 |
| ARKQ | ACHR | ARCHER AVIATION | 184,473 |
| ARKQ | BLDE | BLADE AIR MOBILITY | 227,784 |
| ARKQ | VLD | VELO3D | 438,062 |
| ARKW | SKLZ | SKILLZ | 494,859 |
| ARKW | TDOC | TELADOC HEALTH | 62,024 |
| ARKX | MKFG | MARKFORGED | 70,494 |
Catherine Wood, the CEO and CIO of ARK Investment Management, is a minority and nonvoting shareholder of 24/7 Wall St., owner of 247wallst.com.
Contact [email protected] for any questions or corrections.
Chris Lange is a financial and geopolitical writer with more than a decade of experience covering a myriad of topics. He has published thousands of articles for 24/7 Wall St., with past coverage focused heavily on stocks, IPOs, healthcare, defense, global affairs, and technology.
His work has been quoted, or referenced by a number of outlets including Business Insider, USA Today, Yahoo Finance, MSN, The Motley Fool, and many other publications. A graduate of Southwestern University, he studied business with a focus on investments and has previous experience in banking and startups.
When not reading or writing the news, he is following his passion for Lacrosse, playing chess, or building solar projects with his dad.
